Primary Site >> Liver Cancer
Gene >> S100A4
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Metabolism of estrogens in hepatomas of different growth rates. PMID: 191175 |
Ref: Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. PMID: 15243804 |
Ref: Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. PMID: 17051636 |
Ref: Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. PMID: 17786304 |
Ref: Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. PMID: 17957724 |
Ref: Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS/MS analysis. PMID: 20026004 Ref: Evaluation of glioma-associated oncogene 1 expression and its correlation with the expression of sonic hedgehog, E-cadherin and S100a4 in human hepatocellular carcinoma. PMID: 21472341 |
Ref: Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. PMID: 21173249 Ref: Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. PMID: 22045674 |
Ref: Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis. PMID: 23316018 Ref: Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma. PMID: 23781010 Ref: S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-kappaB-dependent MMP-9 signal. PMID: 24065232 Ref: The Inhibitory Effect of 3 beta -Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells through JNK and Akt Signaling Pathway. PMID: 24379889 |
Ref: Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS. PMID: 24378831 Ref: Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. PMID: 24781336 |
Ref: miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells. PMID: 25769721 Ref: Molecular targets and pathways involved in liver metastasis of colorectal cancer. PMID: 26104118 |
Ref: Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis. PMID: 26219896 Ref: Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(beta-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma. PMID: 26896737 Ref: miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4. PMID: 27544906 |
Ref: Depletion of S100A4(+) stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. PMID: 29303514 Ref: Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy. PMID: 29445087 |